Search

Search Constraints

You searched for: Author/Creator Wong, Stuart

Search Results

2. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. (2nd September 2022)

3. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. (January 2019)

7. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Issue 10212 (23rd November 2019)

8. Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study. (July 2019)

9. Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi‐institutional Study. (12th February 2019)